4//SEC Filing
ARIAD PHARMACEUTICALS INC 4
Accession 0000884731-17-000018
CIK 0000884731operating
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 4:42 PM ET
Size
311.4 KB
Accession
0000884731-17-000018
Insider Transaction Report
Form 4
Bollag Daniel M
Sr. VP, Reg. Affairs & Quality
Transactions
- Tax Payment
Common Stock
2017-01-31$23.81/sh−14,667$349,293→ 126,352 total - Exercise/Conversion
Common Stock
2017-01-31+29,333→ 141,019 total - Exercise/Conversion
Restricted Stock Units
2017-01-31−29,333→ 0 totalExercise: $0.00→ Common Stock (29,333 underlying)
Footnotes (5)
- [F1]Shares were acquired upon the vesting of a Restricted Stock Unit previously granted on January 31, 2014.
- [F2]Shares were sold to satisfy the Company's tax withholding obligations pursuant to a Rule 10b5-1 plan adopted on June 15, 2016.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.795 to $23.83, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the shares sold at each separate price within the range set forth in this footnote.
- [F4]Restricted Stock Units vest as approximately to one-third of the award on each of January 31, 2015, January 31, 2016 and January 31, 2017.
- [F5]N/A
Issuer
ARIAD PHARMACEUTICALS INC
CIK 0000884731
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000884731
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 4:42 PM ET
- Size
- 311.4 KB